Russia has officially announced that a domestically developed personalized mRNA cancer vaccine is ready for clinical use and will be distributed free of charge to cancer patients. The vaccine, developed by the Gamaleya National Research Center, targets tumor-specific neoantigens tailored to each patient’s genetic profile and is expected to launch treatment for patients starting in September-October 2025.The cancer vaccine has …
Read More »
NewsDesk Your trusted news source